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Collagen type I, is a fibrillar protein with a complex hierarchical structure, forming the 
extracellular matrices of an extensive range of organs and tissues. Applications for treated 
collagen materials vary vastly from commercial uses to the medical field for bioprosthetics and 
tissue grafts. Glycosaminoglycan (GAG), cross links naturally bridge fibrils, whilst 
glutaraldehyde is widely used as a synthetic linking agent in medical and other industries. No 
consensus has been reached regarding what contribution, if any, such cross links have on 
collagen structure and mechanical responses to applied stresses. This research investigated 
the role of GAG and glutaraldehyde cross links on the nanostructure and nanostructural 
response of type I collagen fibrils under uniaxial strain. Bovine pericardium was decellularised, 
producing native samples, or further treated with glutaraldehyde or chondroitinase ABC to 
produce glutaraldehyde cross linked or GAG-depleted collagen samples respectively. 
Synchrotron small angle X-ray scattering (SAXS), and atomic force and polarised light 
microscopy provided quantitative and qualitative information on collagen nanostructure. 
Uniaxial tensile experiments in conjunction with SAXS were performed to monitor structural 
changes with applied strain. Glutaraldehyde cross links constrained fibrils into more networked 
isotropic structures and demonstrated a mechanical function, recruiting 45% of fibrils into 
stretching which experienced strains of up to 6.4%. Comparison of native with chondroitinase 
ABC-treated samples showed GAGs do not constrain fibrils into alignment and have potential 
fibril lubricating effects; 12% of fibrils in native tissue experienced strains up to 4.1%, and 36% 
of fibrils experienced strains up to 4.6% in the GAG-depleted tissue. A higher degree of fibril 
sliding occurs in native tissue. Interestingly, whilst adult pericardia are more cross linked and 
fibrils of neonatal pericardia are more aligned, both tissues share similar propensities to form 
more isotropic structures with glutaraldehyde treatment. These findings build a 
comprehensive picture as to the function cross linking has in collagen structure and 
mechanical response at the nano-level, where such knowledge may prove useful for the 
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